FindTrial
Sign In

Comparison of efficacy of combined laser and carbamazepine with only carbamazepine in patients with trigeminal neuralgia : a randomised controlled trial

Comparative evaluation of therapeutic and analgesic effect of combined laser and carbamazepine with carbamazepine alone in patients with trigeminal neuralgia : a randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068319
Enrollment
40
Registered
2024-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G448- Other specified headache syndromes

Interventions

Intervention1: Photobiomodulation therapy as an adjunct to Carbamazepine 100 mg.: Photobiomodulation therapy using a diode laser of 810 nm wavelength will be given to points (extraoral and/or intraora

Sponsors

Saumya Shukla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients clinically diagnosed with TN according to the IHS Classification ICHD-3. 2. Both males and females. 3. Patients who have given informed consent for the study.

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study. 2. Pregnant females. 3. Patients with abnormal CBC and liver function tests.

Design outcomes

Primary

MeasureTime frame
Reduction in pain intensity using McGill Pain Questionnaire.Timepoint: baseline and 3 months—

Secondary

MeasureTime frame
Time taken for 50% pain reduction using VASTimepoint: twice weekly for initial 4 weeks , 1 month, 2 months and 3 months—

Countries

India

Contacts

Public ContactDr Adit

Institute of Medical Sciences, Banaras Hindu University

adit@bhu.ac.in9451525522

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026